Skip to main content

LU Q41 Pill - brown & yellow capsule/oblong, 16mm

Pill with imprint LU Q41 is Brown & Yellow, Capsule/Oblong and has been identified as Fenofibric Acid Delayed-Release 45 mg. It is supplied by Lupin Pharmaceuticals, Inc.

Fenofibric acid is used in the treatment of Hypertriglyceridemia; High Cholesterol and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibric acid 45 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for LU Q41

Fenofibric acid delayed-release 45 mg LU Q41

Fenofibric Acid Delayed-Release

LU Q41
45 mg
Brown & Yellow
16.00 mm
Prescription only
Drug Class
Fibric acid derivatives
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Lupin Pharmaceuticals, Inc.
National Drug Code (NDC)
Inactive Ingredients
silicon dioxide, dibutyl sebacate, ethylcellulose, ferric oxide red, ferric oxide yellow, ferrosoferric oxide, gelatin, hypromelloses, lactose monohydrate, magnesium stearate, methacrylic acid - ethyl acrylate copolymer (1:1) type a, potassium hydroxide, povidone k90, propylene glycol, shellac, sodium lauryl sulfate, sodium stearyl fumarate, magnesium silicate, titanium dioxide, triethyl citrate

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.